Abatacept is effective in Chinese patients with LRBA and CTLA4 deficiency

CTLA4 deficiency and LRBA deficiency are a group disorders of immune dysregulation that affect CTLA4 pathway. The patients mainly present with autoimmunity, antibody deficiency and recurrent infections. Here we reported three Chinese patients with LRBA and CTLA4 mutations. They all presented with ch...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Lu Yang, Xiuhong Xue, Xuemei Chen, Junfeng Wu, Xi Yang, Li Xu, Xuemei Tang, Mo Wang, Huawei Mao, Xiaodong Zhao
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	KeAi Communications Co., Ltd. 2021-09-01
Σειρά:	Genes and Diseases
Θέματα:	LRBA deficiency CTLA4 deficiency Target therapy Abatacept Efficacy
Διαθέσιμο Online:	http://www.sciencedirect.com/science/article/pii/S2352304220300350
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!